22
Growth Score in past quarter
pts
Heat Score 22 in past quarter
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
598442
Arbele Corp is a biotech R&D company focusing on next-gen immunotherapeutic platforms to treat cancer of high mortality
- John Luk: Founder and CEOPast Role: Johnson & Johnson, Senior Director
- Cindy Shek: Founding Director
About the Company
Arbele focuses on acceleration and expansion of immunotherapy technology and product development to treat cancers prevalent in Greater China, Asia-Pacific region and the United States. The company has established a stellar collaboration network with leading academic institutes, biotechs, and medical centers to progress the clinical stages of drug
candidates. The company is founded by reputable scientists and senior executives in drug industries and recently teamed up with experienced professionals in financing, legal and investment.